Header cover image

Belgian Pharmaceuticals & Biotech Sustainable Track Record

Results

1

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

argenx

Market Cap: €50.3b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

ARGX

€804.40

7D

7.0%

1Y

59.6%